Menu Search
Equities

Little Green Pharma Ltd

LGP:ASX

Little Green Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.084
  • Today's Change0.003 / 3.70%
  • Shares traded122.69k
  • 1 Year change-47.50%
  • Beta1.5560
Data delayed at least 20 minutes, as of Sep 20 2024 06:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Little Green Pharma Ltd grew revenues 29.07% from 19.86m to 25.63m while net income improved from a loss of 9.21m to a smaller loss of 8.15m.
Gross margin53.18%
Net profit margin-31.81%
Operating margin-35.75%
Return on assets-8.82%
Return on equity-10.22%
Return on investment-9.74%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at Little Green Pharma Ltd fell by 7.43m. However, the company earned 66.79k from its operations for a Cash Flow Margin of 0.26%. In addition the company used 2.80m on investing activities and also paid 4.72m in financing cash flows.
Cash flow per share-0.0169
Price/Cash flow per share--
Book value per share0.2574
Tangible book value per share0.2459
More ▼

Balance sheet in AUDView more

Little Green Pharma Ltd has a Debt to Total Capital ratio of 6.24%, a lower figure than the previous year's 6.46%.
Current ratio3.34
Quick ratio1.39
Total debt/total equity0.0666
Total debt/total capital0.0624
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.